The prevalence of tumour markers in malignant pleural effusions associated with primary pulmonary adenocarcinoma: a retrospective study

BACKGROUND: Oncological treatment of primary pulmonary adenocarcinoma (AC) includes drugs targeting the pathways involving programmed death-ligand 1 (PD-L1), epidermal growth factor receptor (EGFR) mutation and anaplastic lymphoma kinase (ALK). The aim of the study was to report the prevalence of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Fjaellegaard, Katrine, Koefod Petersen, Jesper, Andersen, Gitte, Biagini, Matteo, Bhatnagar, Rahul, Laursen, Christian B., Clementsen, Paul Frost, Bodtger, Uffe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567952/
https://www.ncbi.nlm.nih.gov/pubmed/34745460
http://dx.doi.org/10.1080/20018525.2021.1984375

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567952/
https://www.ncbi.nlm.nih.gov/pubmed/34745460
http://dx.doi.org/10.1080/20018525.2021.1984375

Ejemplares similares